SI3177670T1 - Hiper-razvejan poli (beta-amino ester) za gensko terapijo - Google Patents

Hiper-razvejan poli (beta-amino ester) za gensko terapijo

Info

Publication number
SI3177670T1
SI3177670T1 SI201531166T SI201531166T SI3177670T1 SI 3177670 T1 SI3177670 T1 SI 3177670T1 SI 201531166 T SI201531166 T SI 201531166T SI 201531166 T SI201531166 T SI 201531166T SI 3177670 T1 SI3177670 T1 SI 3177670T1
Authority
SI
Slovenia
Prior art keywords
beta
gene therapy
amino ester
hyperbranched poly
hyperbranched
Prior art date
Application number
SI201531166T
Other languages
English (en)
Inventor
Wenxin Wang
Dezhong Zhou
Original Assignee
University College Dublin, National University Of Ireland, Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Dublin, National University Of Ireland, Dublin filed Critical University College Dublin, National University Of Ireland, Dublin
Publication of SI3177670T1 publication Critical patent/SI3177670T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/685—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/005—Hyperbranched macromolecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Polyesters Or Polycarbonates (AREA)
SI201531166T 2014-08-06 2015-08-06 Hiper-razvejan poli (beta-amino ester) za gensko terapijo SI3177670T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1413907.5A GB201413907D0 (en) 2014-08-06 2014-08-06 Hyberbranched poly(beta-amino ester) for gene therapy
PCT/EP2015/068153 WO2016020474A1 (en) 2014-08-06 2015-08-06 HYPERBRANCHED POLY( ß -AMINO ESTER) FOR GENE THERAPY
EP15745509.8A EP3177670B1 (en) 2014-08-06 2015-08-06 Hyperbranched poly( beta-amino ester) for gene therapy

Publications (1)

Publication Number Publication Date
SI3177670T1 true SI3177670T1 (sl) 2020-07-31

Family

ID=51587799

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531166T SI3177670T1 (sl) 2014-08-06 2015-08-06 Hiper-razvejan poli (beta-amino ester) za gensko terapijo

Country Status (14)

Country Link
US (1) US20170216455A1 (sl)
EP (2) EP3738992A1 (sl)
CY (1) CY1122850T1 (sl)
DK (1) DK3177670T3 (sl)
ES (1) ES2785248T3 (sl)
GB (1) GB201413907D0 (sl)
HR (1) HRP20200633T1 (sl)
HU (1) HUE049704T2 (sl)
LT (1) LT3177670T (sl)
PL (1) PL3177670T3 (sl)
PT (1) PT3177670T (sl)
RS (1) RS60335B1 (sl)
SI (1) SI3177670T1 (sl)
WO (1) WO2016020474A1 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019084229A1 (en) 2017-10-27 2019-05-02 Massachusetts Institute Of Technology POLY (BETA-AMINO ESTERS) AND USES THEREOF
AU2019356596A1 (en) 2018-10-12 2021-04-08 Amryt Genetics Ltd. Compositions and methods for transfecting cells
CA3117781A1 (en) 2018-10-26 2020-04-30 Massachusetts Institute Of Technology Polymer-lipids and compositions
JP2022515980A (ja) * 2018-12-28 2022-02-24 アムリット・ジェネティクス・リミテッド ポリプレックスを形成するための方法
CA3151988A1 (en) 2019-09-25 2021-04-01 Wenxin Wang Nanoparticle compositions for gene therapy
EP3798250A1 (en) * 2019-09-25 2021-03-31 University College Dublin Hyperbranched cationic polymers useful as nucleic acid delivery vectors for transfecting
CN110746599B (zh) * 2019-09-30 2021-06-18 苏州大学 具有高效基因递送能力的UV光响应性超支化聚β-氨基酯及其制备方法与应用
CN111135306B (zh) * 2020-01-19 2023-03-10 安阳师范学院 基于叶酸靶向聚乙二醇修饰型超支化聚胺制备叶酸和磁性双靶向型非病毒基因载体的方法
WO2022192176A1 (en) * 2021-03-09 2022-09-15 Massachusetts Institute Of Technology Branched poly(-amino esters) for the delivery of nucleic acids
CN114106348B (zh) * 2021-11-12 2023-07-07 西安交通大学 苯硼酸修饰的胞内可降解超支化聚（β-氨基酯）及其制备方法和蛋白递送应用
EP4183884A1 (en) * 2021-11-19 2023-05-24 Branca Bunus Limited A method of preparing a fraction of a starting polymer vector for gene therapy
WO2023131648A1 (en) 2022-01-05 2023-07-13 Branca Bunus Limited Nanoparticulate compositions for gene therapy
EP4324485A1 (en) 2022-08-15 2024-02-21 Branca Banus Ltd A method for the production of pegylated hyperbranched poly( -amino ester)s, pegylated hyperbranched poly( -amino ester)s produced by those methods and their use in enhanced nucleic acid delivery
CN116003787A (zh) * 2023-01-15 2023-04-25 西安交通大学 含疏水烷基链的高度支化聚（β-氨基酯）及其制备方法和mRNA递送应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180424A (en) * 1991-10-07 1993-01-19 Westvaco Corporation Michael addition aminopolyester resins as dilution extenders for zinc-containing metal resinate inks
US6998115B2 (en) 2000-10-10 2006-02-14 Massachusetts Institute Of Technology Biodegradable poly(β-amino esters) and uses thereof
WO2006118547A1 (en) * 2005-04-29 2006-11-09 Agency For Science, Technology And Research Hyperbranched polymers and their applications
CA2658768C (en) * 2006-07-21 2016-05-17 Massachusetts Institute Of Technology End-modified poly(beta-amino esters) and uses thereof

Also Published As

Publication number Publication date
EP3738992A1 (en) 2020-11-18
US20170216455A1 (en) 2017-08-03
ES2785248T3 (es) 2020-10-06
HRP20200633T1 (hr) 2020-08-07
CY1122850T1 (el) 2021-05-05
LT3177670T (lt) 2020-06-25
PT3177670T (pt) 2020-04-24
WO2016020474A1 (en) 2016-02-11
GB201413907D0 (en) 2014-09-17
EP3177670B1 (en) 2020-03-18
RS60335B1 (sr) 2020-07-31
HUE049704T2 (hu) 2020-10-28
EP3177670A1 (en) 2017-06-14
DK3177670T3 (da) 2020-04-27
PL3177670T3 (pl) 2020-07-13

Similar Documents

Publication Publication Date Title
SI3177670T1 (sl) Hiper-razvejan poli (beta-amino ester) za gensko terapijo
IL284577A (en) Garden healing
ZA201604874B (en) Rna-guided gene drives
IL251468A0 (en) aav-based gene therapy
SG11201704681QA (en) Artificial nucleic acid molecules
GB201402261D0 (en) Injector apparatus
GB201615324D0 (en) Charge pump stability control
GB201420139D0 (en) Factor IX gene therapy
GB201407322D0 (en) Gene therapy
DK3191139T3 (da) RPGR-genterapi til retinitis pigmentosa
IL262310A (en) Advanced methods of gene insertion
RS60816B1 (sr) Genska terapija za multiplu sklerozu bazirana na aav
GB2532929B (en) Coolant injection controller
IL257500A (en) Altered cullin1 gene
EP3191034A4 (en) Injector apparatus
HK1221683A1 (zh) 遊戲控制器
GB201419891D0 (en) Game controller
GB2531245B (en) Ramp
IL263085A (en) Garden healing
GB201616821D0 (en) Gene therapy
GB201612104D0 (en) Gene therapy
GB201612105D0 (en) Gene therapy
GB201507125D0 (en) Gene delivery
GB201410595D0 (en) Factor IX gene therapy
SG10201912076UA (en) Gene therapy composition